Cite
Holmes AD, Waite KA, Chen MC, et al. Dermatological Adverse Events Associated with Topical Brimonidine Gel 0.33% in Subjects with Erythema of Rosacea: A Retrospective Review of Clinical Studies. J Clin Aesthet Dermatol. 2015;8(8):29-35
Holmes, A. D., Waite, K. A., Chen, M. C., Palaniswamy, K., Wiser, T. H., Draelos, Z. D., Rafal, E. S., Werschler, W. P., & Harvey, A. E. (2015). Dermatological Adverse Events Associated with Topical Brimonidine Gel 0.33% in Subjects with Erythema of Rosacea: A Retrospective Review of Clinical Studies. The Journal of clinical and aesthetic dermatology, 8(8), 29-35.
Holmes, Anna D, et al. "Dermatological Adverse Events Associated with Topical Brimonidine Gel 0.33% in Subjects with Erythema of Rosacea: A Retrospective Review of Clinical Studies." The Journal of clinical and aesthetic dermatology vol. 8,8 (2015): 29-35.
Holmes AD, Waite KA, Chen MC, Palaniswamy K, Wiser TH, Draelos ZD, Rafal ES, Werschler WP, Harvey AE. Dermatological Adverse Events Associated with Topical Brimonidine Gel 0.33% in Subjects with Erythema of Rosacea: A Retrospective Review of Clinical Studies. J Clin Aesthet Dermatol. 2015 Aug;8(8):29-35. PMID: 26345379; PMCID: PMC4557848.
Copy
Download .nbib